MediPharm Labs Reports Significant Financial Growth in Q4
Wednesday, 27 March 2024, 10:37
MediPharm Labs Q4 Financial Report
MediPharm Labs' latest Q4 report reveals substantial growth metrics, highlighted by a 55% increase in Adjusted EBITDA to negative $1.6M and an impressive 62.5% YoY revenue uptick reaching C$9.13M.
Key Highlights:
- Adjusted EBITDA improvement: 55%
- Revenue growth: 62.5% YoY
The company's financial results signify strong progress and a positive trajectory for MediPharm Labs.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.